Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-10-28 Purchase | 2024-10-30 4:17 pm | Monopar Therapeutics | MNPR | Radhakrishnan Karthik Chief Financial Officer | 1,550 | $16.25 | $25,188 | 1,550 (Direct) | View |
| 2024-06-18 Purchase | 2024-06-21 5:16 pm | Monopar Therapeutics | MNPR | Cittadine Andrew Chief Operating Officer | 32,508 | $0.78669 | $25,574 | 186,132 (Direct) | View |
| 2024-06-13 Purchase | 2024-06-17 6:08 pm | Monopar Therapeutics | MNPR | Cittadine Andrew Chief Operating Officer | 36,000 | $0.91373 | $32,894 | 153,624 (Direct) | View |
| 2024-06-03 Purchase | 2024-06-05 6:12 pm | Monopar Therapeutics | MNPR | Cittadine Andrew Chief Operating Officer | 24,000 | $0.77 | $18,480 | 117,624 (Direct) | View |
| 2024-05-29 Purchase | 2024-05-31 4:56 pm | Monopar Therapeutics | MNPR | Cittadine Andrew Chief Operating Officer | 36,000 | $0.6403 | $23,051 | 93,624 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-09-30 Exercise | 2024-10-02 7:45 pm | N/A N/A | Monopar Therapeutics | MNPR | Robinson Chandler Chief Executive Officer | 4,895 | $0 | 941,525 (Direct) | View |
| 2024-09-30 Tax Withholding | 2024-10-02 7:45 pm | N/A N/A | Monopar Therapeutics | MNPR | Robinson Chandler Chief Executive Officer | 1,918 | $6.74 | 941,525 (Direct) | View |
| 2024-09-30 Exercise | 2024-10-02 7:44 pm | N/A N/A | Monopar Therapeutics | MNPR | Cittadine Andrew Chief Operating Officer | 1,791 | $0 | 52,733 (Direct) | View |
| 2024-09-30 Tax Withholding | 2024-10-02 7:44 pm | N/A N/A | Monopar Therapeutics | MNPR | Cittadine Andrew Chief Operating Officer | 535 | $6.74 | 52,733 (Direct) | View |
| 2024-07-01 Option Award | 2024-07-03 6:22 pm | N/A 2034-06-30 | Monopar Therapeutics | MNPR | Radhakrishnan Karthik Chief Financial Officer | 125,000 | $0 | 125,000 (Direct) | View |
| 2024-06-30 Exercise | 2024-07-02 6:12 pm | N/A N/A | Monopar Therapeutics | MNPR | Cittadine Andrew Chief Operating Officer | 8,952 | $0 | 266,336 (Direct) | View |
| 2024-06-30 Tax Withholding | 2024-07-02 6:12 pm | N/A N/A | Monopar Therapeutics | MNPR | Cittadine Andrew Chief Operating Officer | 2,019 | $0.731 | 266,336 (Direct) | View |
| 2024-06-30 Exercise | 2024-07-02 6:08 pm | N/A N/A | Monopar Therapeutics | MNPR | Tsuchimoto Kim R Chief Financial Officer | 9,957 | $0 | 131,841 (Direct) | View |
| 2024-06-30 Tax Withholding | 2024-07-02 6:08 pm | N/A N/A | Monopar Therapeutics | MNPR | Tsuchimoto Kim R Chief Financial Officer | 2,998 | $0.731 | 131,841 (Direct) | View |
| 2024-06-30 Exercise | 2024-07-02 6:07 pm | N/A N/A | Monopar Therapeutics | MNPR | Robinson Chandler Chief Executive Officer | 24,476 | $0 | 4,717,198 (Direct) | View |
| 2024-06-30 Tax Withholding | 2024-07-02 6:07 pm | N/A N/A | Monopar Therapeutics | MNPR | Robinson Chandler Chief Executive Officer | 8,684 | $0.731 | 4,717,198 (Direct) | View |
| 2024-05-28 Exercise | 2024-05-30 6:10 pm | N/A N/A | Monopar Therapeutics | MNPR | Robinson Chandler Chief Executive Officer | 84,000 | $0.001 | 4,528,071 (Direct) | View |
| 2024-05-28 Exercise | 2024-05-30 6:10 pm | N/A 2026-04-03 | Monopar Therapeutics | MNPR | Robinson Chandler Chief Executive Officer | 84,000 | $0 | 4,528,071 (Direct) | View |
| 2024-05-22 Option Award | 2024-05-24 4:59 pm | N/A 2034-05-22 | Monopar Therapeutics | MNPR | Cittadine Andrew Chief Operating Officer | 25,000 | $0 | 25,000 (Direct) | View |
| 2024-03-31 Exercise | 2024-04-02 8:35 pm | N/A N/A | Monopar Therapeutics | MNPR | Cittadine Andrew Chief Operating Officer | 8,952 | $0 | 139,847 (Direct) | View |
| 2024-03-31 Tax Withholding | 2024-04-02 8:35 pm | N/A N/A | Monopar Therapeutics | MNPR | Cittadine Andrew Chief Operating Officer | 3,098 | $0.681 | 139,847 (Direct) | View |
| 2024-03-31 Exercise | 2024-04-02 8:33 pm | N/A N/A | Monopar Therapeutics | MNPR | Tsuchimoto Kim R Chief Financial Officer | 9,956 | $0 | 134,839 (Direct) | View |
| 2024-03-31 Tax Withholding | 2024-04-02 8:33 pm | N/A N/A | Monopar Therapeutics | MNPR | Tsuchimoto Kim R Chief Financial Officer | 4,082 | $0.681 | 134,839 (Direct) | View |
| 2024-03-31 Exercise | 2024-04-02 8:33 pm | N/A N/A | Monopar Therapeutics | MNPR | Robinson Chandler Chief Executive Officer | 24,474 | $0 | 4,641,882 (Direct) | View |
| 2024-03-31 Tax Withholding | 2024-04-02 8:33 pm | N/A N/A | Monopar Therapeutics | MNPR | Robinson Chandler Chief Executive Officer | 7,172 | $0.681 | 4,641,882 (Direct) | View |
| 2023-12-31 Exercise | 2024-01-03 7:40 pm | N/A N/A | Monopar Therapeutics | MNPR | Anderson Raymond Director | 2,533 | $0 | 26,863 (Direct) | View |
| 2023-12-31 Exercise | 2024-01-03 7:40 pm | N/A N/A | Monopar Therapeutics | MNPR | Brown Michael J Director | 2,533 | $0 | 4,513,803 (Direct) | View |
| 2023-12-31 Exercise | 2024-01-03 7:39 pm | N/A N/A | Monopar Therapeutics | MNPR | Cittadine Andrew Chief Operating Officer | 8,952 | $0 | 142,945 (Direct) | View |
| 2023-12-31 Tax Withholding | 2024-01-03 7:39 pm | N/A N/A | Monopar Therapeutics | MNPR | Cittadine Andrew Chief Operating Officer | 3,098 | $0.3402 | 142,945 (Direct) | View |
| 2023-12-31 Exercise | 2024-01-03 7:38 pm | N/A N/A | Monopar Therapeutics | MNPR | KLAUSNER ARTHUR J Director | 2,533 | $0 | 3,086,257 (Direct) | View |
| 2023-12-31 Exercise | 2024-01-03 7:37 pm | N/A N/A | Monopar Therapeutics | MNPR | STARR CHRISTOPHER M Director | 2,533 | $0 | 75,263 (Direct) | View |
| 2023-12-31 Exercise | 2024-01-03 7:36 pm | N/A N/A | Monopar Therapeutics | MNPR | Robinson Chandler Chief Executive Officer | 31,198 | $0 | 9,156,003 (Direct) | View |
| 2023-12-31 Tax Withholding | 2024-01-03 7:36 pm | N/A N/A | Monopar Therapeutics | MNPR | Robinson Chandler Chief Executive Officer | 10,796 | $0.3402 | 9,156,003 (Direct) | View |
| 2023-12-31 Exercise | 2024-01-03 7:34 pm | N/A N/A | Monopar Therapeutics | MNPR | Tsuchimoto Kim R Chief Financial Officer | 11,188 | $0 | 234,477 (Direct) | View |
| 2023-12-31 Tax Withholding | 2024-01-03 7:34 pm | N/A N/A | Monopar Therapeutics | MNPR | Tsuchimoto Kim R Chief Financial Officer | 4,578 | $0.3402 | 234,477 (Direct) | View |
| 2024-01-01 Option Award | 2024-01-03 7:33 pm | N/A 2033-12-31 | Monopar Therapeutics | MNPR | RIOUX PATRICE Acting Chief Medical Officer | 10,000 | $0 | 10,000 (Direct) | View |
| 2023-09-30 Exercise | 2023-10-03 7:37 pm | N/A N/A | Monopar Therapeutics | MNPR | Robinson Chandler Chief Executive Officer | 24,474 | $0 | 4,659,850 (Direct) | View |
| 2023-09-30 Tax Withholding | 2023-10-03 7:37 pm | N/A N/A | Monopar Therapeutics | MNPR | Robinson Chandler Chief Executive Officer | 7,172 | $0.6199 | 4,659,850 (Direct) | View |
| 2023-09-30 Exercise | 2023-10-03 7:36 pm | N/A N/A | Monopar Therapeutics | MNPR | Tsuchimoto Kim R Chief Financial Officer | 9,956 | $0 | 143,499 (Direct) | View |
| 2023-09-30 Tax Withholding | 2023-10-03 7:36 pm | N/A N/A | Monopar Therapeutics | MNPR | Tsuchimoto Kim R Chief Financial Officer | 3,444 | $0.6199 | 143,499 (Direct) | View |
| 2023-09-30 Exercise | 2023-10-03 7:35 pm | N/A N/A | Monopar Therapeutics | MNPR | STARR CHRISTOPHER M Director | 2,533 | $0 | 75,263 (Direct) | View |
| 2023-09-30 Exercise | 2023-10-03 7:34 pm | N/A N/A | Monopar Therapeutics | MNPR | KLAUSNER ARTHUR J Director | 2,533 | $0 | 3,086,257 (Direct) | View |
| 2023-09-30 Exercise | 2023-10-03 7:32 pm | N/A N/A | Monopar Therapeutics | MNPR | Brown Michael J Director | 2,533 | $0 | 4,513,803 (Direct) | View |
| 2023-09-30 Exercise | 2023-10-03 7:31 pm | N/A N/A | Monopar Therapeutics | MNPR | Anderson Raymond Director | 2,533 | $0 | 26,863 (Direct) | View |
| 2023-09-30 Exercise | 2023-10-03 7:30 pm | N/A N/A | Monopar Therapeutics | MNPR | Cittadine Andrew Chief Operating Officer | 8,953 | $0 | 146,043 (Direct) | View |
| 2023-09-30 Tax Withholding | 2023-10-03 7:30 pm | N/A N/A | Monopar Therapeutics | MNPR | Cittadine Andrew Chief Operating Officer | 2,624 | $0.6199 | 146,043 (Direct) | View |
| 2023-06-30 Exercise | 2023-07-03 6:51 pm | N/A N/A | Monopar Therapeutics | MNPR | Cittadine Andrew Chief Operating Officer | 13,841 | $0 | 148,667 (Direct) | View |
| 2023-06-30 Tax Withholding | 2023-07-03 6:51 pm | N/A N/A | Monopar Therapeutics | MNPR | Cittadine Andrew Chief Operating Officer | 4,057 | $0.855 | 148,667 (Direct) | View |
| 2023-06-30 Exercise | 2023-07-03 6:50 pm | N/A N/A | Monopar Therapeutics | MNPR | Anderson Raymond Director | 2,534 | $0 | 26,863 (Direct) | View |
| 2023-06-30 Exercise | 2023-07-03 6:49 pm | N/A N/A | Monopar Therapeutics | MNPR | Brown Michael J Director | 2,534 | $0 | 4,513,803 (Direct) | View |
| 2023-06-30 Exercise | 2023-07-03 6:49 pm | N/A N/A | Monopar Therapeutics | MNPR | KLAUSNER ARTHUR J Director | 2,534 | $0 | 3,086,257 (Direct) | View |
| 2023-06-30 Exercise | 2023-07-03 6:46 pm | N/A N/A | Monopar Therapeutics | MNPR | STARR CHRISTOPHER M Director | 2,534 | $0 | 75,263 (Direct) | View |
| 2023-06-30 Exercise | 2023-07-03 6:46 pm | N/A N/A | Monopar Therapeutics | MNPR | Tsuchimoto Kim R Chief Financial Officer | 14,846 | $0 | 146,943 (Direct) | View |
| 2023-06-30 Tax Withholding | 2023-07-03 6:46 pm | N/A N/A | Monopar Therapeutics | MNPR | Tsuchimoto Kim R Chief Financial Officer | 5,104 | $0.855 | 146,943 (Direct) | View |
| 2023-06-30 Exercise | 2023-07-03 6:45 pm | N/A N/A | Monopar Therapeutics | MNPR | Robinson Chandler Chief Executive Officer | 35,039 | $0 | 4,667,022 (Direct) | View |
| 2023-06-30 Tax Withholding | 2023-07-03 6:45 pm | N/A N/A | Monopar Therapeutics | MNPR | Robinson Chandler Chief Executive Officer | 10,269 | $0.855 | 4,667,022 (Direct) | View |
| 2023-03-31 Exercise | 2023-04-04 5:21 pm | N/A N/A | Monopar Therapeutics | MNPR | STARR CHRISTOPHER M Director | 2,533 | $0 | 75,263 (Direct) | View |